国际工作组临床实践指南关于儿童和成人X相关低血症的方法
Dalal S Ali1, Aliya A Khan2, Reza D Mirza3
1Divisions of Endocrinology and Metabolism, McMaster University, 223 3075 Hospital Gate, Oakville, ON, L6M 1M1, Canada.
Journal of bone and mineral metabolism
|March 22, 2025
概括
新的X链接低血症指南 (XLH) 提供了专家对儿童和成人诊断和治疗的建议. 这些基于证据的指导方针涉及医疗疗法和患者监测,以改善XLH管理.
科学领域:
- 医学指导方针 医学指导方针
- 罕见疾病 罕见疾病
- 儿科和成人内分泌学
背景情况:
- 与X相关的低血症 (XLH) 是一种罕见的遗传疾病,影响骨和矿物质代谢.
- 目前的管理策略需要更新,基于证据的指导方针,以获得最佳的患者护理.
研究的目的:
- 为儿童和成人群体诊断和管理XLH制定全面的,基于证据的指导方针.
- 提供关于医疗疗法,患者监测和特定临床情景的建议.
主要方法:
- 用推,评估,开发和评估 (GRADE) 方法对一组问题进行分级.
- 对布罗苏马布和酸盐/活性维生素D疗法的影响进行了系统审查.
- 进行了专家临床实践调查和叙事文献评论,用于非GRADE建议.
主要成果:
- 为成年人制定了三项GRADE治疗建议,为儿童制定了两项治疗建议.
- 由于证据有限,为XLH患者监测制定了质量非常低的GRADE-ed建议.
- 为孕妇和患有牙科并发症的患者生成非GRADE建议.
结论:
- 开发的指导方针为基于严格的方法的XLH诊断和管理提供了一个框架.
- 建议涵盖了GRADE和非GRADE的两个方面,承认证据的局限性.
- 这些指导方针旨在标准化和改善对X链接低血症患者的护理.
相关概念视频
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
Sex-linked Disorders
101.8K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
101.8K


